biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > New Questions

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Jun 09, 2023 7:54pm

155 Views

Post# 35489538

RE:RE:RE:RE:RE:RE:RE:RE:New Questions

Boomskid wrote: Food banks, poof?

Are you suggesting that pharmas can't afford to develop new drugs?

I thought they couldn't afford NOT to develop new drugs. I suspect that's what THEY think.

You're far out to sea, poof, without a hat.

jd

Hey Johnny boy.

I betcha POF hasnt had to declares bankruptcy!

And Im pretty sure he doesn't live in a Trailer park.

But hey, he just isn't as smart as you.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market